SlideShare a Scribd company logo
1 of 2
Download to read offline
2
1

FILTERING FOR COMPOUND HETEROZYGOUS
SEQUENCE VARIANTS IN NON-CONSANGUINEOUS PEDIGREES
INTRODUCTION: The identification of disease-causing

pathogenic mutations have arisen from recessive

mutations in next-generation sequencing (NGS) da-

genes in the human population over time. It means

ta requires efficient filtering techniques. In patients

the lower the kinship of the parents the higher is the

with rare recessive diseases, compound heterozy-

chance that two different mutant alleles of the dis-

gosity of pathogenic mutations is the likeliest inher-

ease-causing gene are present. Hence, this can be

itance model if the parents are non-consanguineous.

translated into a simple rule of thumb: If the parents

GENETALK has implemented the compound heterozygouse filter option in the INHERITANCE FILTER. It

are non-consanguineous, compound heterozygosity is
the likeliest explanation for a recessive disease .

becomes available when in the filtering options,

A challenge in filtering sequence variants for com-

when a VCF file contains at least a set of three indi-

pound heterozygotes is that one has to figure out

viduals (trio) and the corresponding pedigree is set.

whether the two heterozygous variants affect differ-

BACKGROUND: In recessive genetic disorders all copies of a certain gene are malfunctioning. For autosomal recessive genes this means that the maternally
as well as the paternally inherited copy of a gene
harbors a pathogenic mutation. The occurrence of a
mutation is a random process and many different

ent copies of a gene or the same copy. Usually, that
cannot be determined from a single DNA sequence,
when the read length is smaller than the distance
between the variants. However, when exome data
of more than one family member is available, one
can exclude certain variants based on rules of Mendelian inheritance (box).

RECESSIVE COMPOUND HETEROZYGOUS FILTER RULES
To show only variants that are transmitted in a compound heterozygous mode from parents to the patient,
they have to meet the following conditions:
1. A variant has to be heterozygous in all affected individuals.
2. A variant must not be homozygous in any of the unaffected individuals.
3. A variant that is heterozygous in an affected child has to be heterozygous in exactly one of the parents.
a. The variant must not be heterozygous in both parents.
b. The variant has to be present in at least one parent.
4. A gene must have two or more heterozygous variants in each of the affected individuals.
5. There must be at least one variant transmitted from the paternal side and one transmitted from the maternal side.

www.gene-talk.de
4
3

EXAMPLE: Analysis of exome data from a family with

and scientific evidence of the variant calls, reveals

two siblings affected by Mabry syndrome (also known

PIGO as the disease candidate gene and the muta-

as hyperphosphatasia with mental retardation syn-

tions were confirmed as the causative mutations of

drome) demonstrates how effective the inheritance

the disorder.

filter reduced the amount of sequence variants.
Starting with 27,584 variants the data was filtered

CONCLUSION: The rule set, on which the filter is

for genotype frequency (0.1%), and effects on pro-

based, is comprehensive for analyzing multiple sam-

tein level leaving over only 1446 variants. The com-

ples and advances the prioritization of compound

pound heterozygous filter reduces this set to just six

heterozygous variants. It shows that filtering for

variants in three distinct genes, NBPF10, MUC4, and

compound heterozygous mutations is an effective

PIGO. A quick assessment of the medical relevance

means in identifying disease candidate genes especially when several family
members are available for
the analysis. In a trio analysis e.g. with exome data of
the parents and one affected child, only about a dozen of variants in candidate
genes remain after applying
the filter. This manageable
number of remaining genes
can then be assessed based
on the expertise of the investigator or further prioritized by suitable tools at
www.Gene-Talk.de.

REFERENCE:
Krawitz PM, Murakami Y, Hecht J, Kruger U, Holder SE et al., Mutations in PIGO, a member of the GPI-anchor-synthesis
pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet, 2012, 91: 146-151.
Kamphans T, Sabri P, Zhu N, Heinrich V, Mundlos S, et al., Filtering for Compound Heterozygous Sequence Variants in NonConsanguineous Pedigrees. PLoS ONE, 2013, 8(8): e70151.

www.gene-talk.de

More Related Content

What's hot

Gardner and Song_2015_Genetics in Medicine
Gardner and Song_2015_Genetics in MedicineGardner and Song_2015_Genetics in Medicine
Gardner and Song_2015_Genetics in MedicineAmanda Natalizio
 
Gene therapy: Where do we stand
Gene therapy: Where do we standGene therapy: Where do we stand
Gene therapy: Where do we standIOSR Journals
 
J. Clin. Microbiol.-2014-Davidson-JCM.01144-14
J. Clin. Microbiol.-2014-Davidson-JCM.01144-14J. Clin. Microbiol.-2014-Davidson-JCM.01144-14
J. Clin. Microbiol.-2014-Davidson-JCM.01144-14PreveenRamamoorthy
 
Abstract_Jose_Chang_Leng_08.01.2014
Abstract_Jose_Chang_Leng_08.01.2014Abstract_Jose_Chang_Leng_08.01.2014
Abstract_Jose_Chang_Leng_08.01.2014Jose R. Chang
 
Nihms379831 stephen quake
Nihms379831 stephen quakeNihms379831 stephen quake
Nihms379831 stephen quake鋒博 蔡
 
Transfer of dna between bacterial cell
Transfer of dna between bacterial cellTransfer of dna between bacterial cell
Transfer of dna between bacterial cellmah neem mah
 
Human genome project 2007
Human genome project 2007Human genome project 2007
Human genome project 2007Hesham Gaber
 
Microhaplotype, A Powerful New Type of Genetic Marker
Microhaplotype, A Powerful New Type of Genetic MarkerMicrohaplotype, A Powerful New Type of Genetic Marker
Microhaplotype, A Powerful New Type of Genetic MarkerMojgan Talebian
 
Dna profiling presentation x2
Dna profiling presentation x2Dna profiling presentation x2
Dna profiling presentation x2Eli Rosenthal
 
Lombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory SignatureLombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory Signaturedegarden
 
Symmetric & Asymmetric Hybrid and Cybrid
Symmetric & Asymmetric Hybrid and CybridSymmetric & Asymmetric Hybrid and Cybrid
Symmetric & Asymmetric Hybrid and CybridGauravrajsinh Vaghela
 

What's hot (20)

Gardner and Song_2015_Genetics in Medicine
Gardner and Song_2015_Genetics in MedicineGardner and Song_2015_Genetics in Medicine
Gardner and Song_2015_Genetics in Medicine
 
Gene therapy: Where do we stand
Gene therapy: Where do we standGene therapy: Where do we stand
Gene therapy: Where do we stand
 
AIDS_21(7)_807-811
AIDS_21(7)_807-811AIDS_21(7)_807-811
AIDS_21(7)_807-811
 
Conjugation
ConjugationConjugation
Conjugation
 
J. Clin. Microbiol.-2014-Davidson-JCM.01144-14
J. Clin. Microbiol.-2014-Davidson-JCM.01144-14J. Clin. Microbiol.-2014-Davidson-JCM.01144-14
J. Clin. Microbiol.-2014-Davidson-JCM.01144-14
 
Abstract_Jose_Chang_Leng_08.01.2014
Abstract_Jose_Chang_Leng_08.01.2014Abstract_Jose_Chang_Leng_08.01.2014
Abstract_Jose_Chang_Leng_08.01.2014
 
Ngs pgd
Ngs pgdNgs pgd
Ngs pgd
 
Nihms379831 stephen quake
Nihms379831 stephen quakeNihms379831 stephen quake
Nihms379831 stephen quake
 
Presentación del plegable
Presentación del plegablePresentación del plegable
Presentación del plegable
 
Genetics
GeneticsGenetics
Genetics
 
Transfer of dna between bacterial cell
Transfer of dna between bacterial cellTransfer of dna between bacterial cell
Transfer of dna between bacterial cell
 
Applications of molecular genetics
Applications of molecular geneticsApplications of molecular genetics
Applications of molecular genetics
 
Human cardiac gene therapy
Human cardiac gene therapyHuman cardiac gene therapy
Human cardiac gene therapy
 
Molecular biology
Molecular biologyMolecular biology
Molecular biology
 
Human genome project 2007
Human genome project 2007Human genome project 2007
Human genome project 2007
 
Microhaplotype, A Powerful New Type of Genetic Marker
Microhaplotype, A Powerful New Type of Genetic MarkerMicrohaplotype, A Powerful New Type of Genetic Marker
Microhaplotype, A Powerful New Type of Genetic Marker
 
Dna profiling presentation x2
Dna profiling presentation x2Dna profiling presentation x2
Dna profiling presentation x2
 
Lombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory SignatureLombardi et al: XMRV/CFS Inflammatory Signature
Lombardi et al: XMRV/CFS Inflammatory Signature
 
Qpcr
QpcrQpcr
Qpcr
 
Symmetric & Asymmetric Hybrid and Cybrid
Symmetric & Asymmetric Hybrid and CybridSymmetric & Asymmetric Hybrid and Cybrid
Symmetric & Asymmetric Hybrid and Cybrid
 

Similar to GeneTalk Compound Heterozygous Filtering Whitepaper

Gene hunting strategies
Gene hunting strategiesGene hunting strategies
Gene hunting strategiesAshfaq Ahmad
 
Report- Genome wide association studies.
Report- Genome wide association studies.Report- Genome wide association studies.
Report- Genome wide association studies.Varsha Gayatonde
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingJoaquin Dopazo
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicJoaquin Dopazo
 
DNA Sequencing in Phylogeny
DNA Sequencing in PhylogenyDNA Sequencing in Phylogeny
DNA Sequencing in PhylogenyBikash1489
 
Molecular markers for measuring genetic diversity
Molecular markers for measuring genetic diversity Molecular markers for measuring genetic diversity
Molecular markers for measuring genetic diversity Zohaib HUSSAIN
 
Form 5 chapter 9-variation
Form 5 chapter 9-variationForm 5 chapter 9-variation
Form 5 chapter 9-variationBong Tong
 
GENETIC MUTATIONS IN PERIODONTAL DISEASE.pptx
GENETIC MUTATIONS IN PERIODONTAL DISEASE.pptxGENETIC MUTATIONS IN PERIODONTAL DISEASE.pptx
GENETIC MUTATIONS IN PERIODONTAL DISEASE.pptxViola Esther
 
How Can Ngs Forward Research Essay
How Can Ngs Forward Research EssayHow Can Ngs Forward Research Essay
How Can Ngs Forward Research EssayStefanie Yang
 
GENETICS & periodontal disease.pptx
GENETICS & periodontal disease.pptxGENETICS & periodontal disease.pptx
GENETICS & periodontal disease.pptxMaria Antony Dhivyan
 
allele distributionIn population genetics, allele frequencies are.pdf
allele distributionIn population genetics, allele frequencies are.pdfallele distributionIn population genetics, allele frequencies are.pdf
allele distributionIn population genetics, allele frequencies are.pdfaparnaagenciestvm
 
Sophie F. summer Poster Final
Sophie F. summer Poster FinalSophie F. summer Poster Final
Sophie F. summer Poster FinalSophie Friedheim
 
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...Antoaneta Vladimirova
 
Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...Joaquin Dopazo
 
GENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdfGENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdfShanuSoni7
 

Similar to GeneTalk Compound Heterozygous Filtering Whitepaper (20)

Gene hunting strategies
Gene hunting strategiesGene hunting strategies
Gene hunting strategies
 
Report- Genome wide association studies.
Report- Genome wide association studies.Report- Genome wide association studies.
Report- Genome wide association studies.
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene finding
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
 
DNA Sequencing in Phylogeny
DNA Sequencing in PhylogenyDNA Sequencing in Phylogeny
DNA Sequencing in Phylogeny
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Schizophrenia - Genetics
Schizophrenia - GeneticsSchizophrenia - Genetics
Schizophrenia - Genetics
 
Molecular markers for measuring genetic diversity
Molecular markers for measuring genetic diversity Molecular markers for measuring genetic diversity
Molecular markers for measuring genetic diversity
 
Form 5 chapter 9-variation
Form 5 chapter 9-variationForm 5 chapter 9-variation
Form 5 chapter 9-variation
 
GENETIC MUTATIONS IN PERIODONTAL DISEASE.pptx
GENETIC MUTATIONS IN PERIODONTAL DISEASE.pptxGENETIC MUTATIONS IN PERIODONTAL DISEASE.pptx
GENETIC MUTATIONS IN PERIODONTAL DISEASE.pptx
 
How Can Ngs Forward Research Essay
How Can Ngs Forward Research EssayHow Can Ngs Forward Research Essay
How Can Ngs Forward Research Essay
 
GENETICS & periodontal disease.pptx
GENETICS & periodontal disease.pptxGENETICS & periodontal disease.pptx
GENETICS & periodontal disease.pptx
 
allele distributionIn population genetics, allele frequencies are.pdf
allele distributionIn population genetics, allele frequencies are.pdfallele distributionIn population genetics, allele frequencies are.pdf
allele distributionIn population genetics, allele frequencies are.pdf
 
Sophie F. summer Poster Final
Sophie F. summer Poster FinalSophie F. summer Poster Final
Sophie F. summer Poster Final
 
Presentation1population neutral theory
Presentation1population neutral theoryPresentation1population neutral theory
Presentation1population neutral theory
 
Family history
Family history Family history
Family history
 
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
A Retrospective Analysis of Exome Sequencing Cases Using the GenePool™ Genomi...
 
Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...Digging into thousands of variants to find disease genes in Mendelian and com...
Digging into thousands of variants to find disease genes in Mendelian and com...
 
GENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdfGENETICS IN PSYCHIATRY.pdf
GENETICS IN PSYCHIATRY.pdf
 
1471 2148-6-99
1471 2148-6-991471 2148-6-99
1471 2148-6-99
 

GeneTalk Compound Heterozygous Filtering Whitepaper

  • 1. 2 1 FILTERING FOR COMPOUND HETEROZYGOUS SEQUENCE VARIANTS IN NON-CONSANGUINEOUS PEDIGREES INTRODUCTION: The identification of disease-causing pathogenic mutations have arisen from recessive mutations in next-generation sequencing (NGS) da- genes in the human population over time. It means ta requires efficient filtering techniques. In patients the lower the kinship of the parents the higher is the with rare recessive diseases, compound heterozy- chance that two different mutant alleles of the dis- gosity of pathogenic mutations is the likeliest inher- ease-causing gene are present. Hence, this can be itance model if the parents are non-consanguineous. translated into a simple rule of thumb: If the parents GENETALK has implemented the compound heterozygouse filter option in the INHERITANCE FILTER. It are non-consanguineous, compound heterozygosity is the likeliest explanation for a recessive disease . becomes available when in the filtering options, A challenge in filtering sequence variants for com- when a VCF file contains at least a set of three indi- pound heterozygotes is that one has to figure out viduals (trio) and the corresponding pedigree is set. whether the two heterozygous variants affect differ- BACKGROUND: In recessive genetic disorders all copies of a certain gene are malfunctioning. For autosomal recessive genes this means that the maternally as well as the paternally inherited copy of a gene harbors a pathogenic mutation. The occurrence of a mutation is a random process and many different ent copies of a gene or the same copy. Usually, that cannot be determined from a single DNA sequence, when the read length is smaller than the distance between the variants. However, when exome data of more than one family member is available, one can exclude certain variants based on rules of Mendelian inheritance (box). RECESSIVE COMPOUND HETEROZYGOUS FILTER RULES To show only variants that are transmitted in a compound heterozygous mode from parents to the patient, they have to meet the following conditions: 1. A variant has to be heterozygous in all affected individuals. 2. A variant must not be homozygous in any of the unaffected individuals. 3. A variant that is heterozygous in an affected child has to be heterozygous in exactly one of the parents. a. The variant must not be heterozygous in both parents. b. The variant has to be present in at least one parent. 4. A gene must have two or more heterozygous variants in each of the affected individuals. 5. There must be at least one variant transmitted from the paternal side and one transmitted from the maternal side. www.gene-talk.de
  • 2. 4 3 EXAMPLE: Analysis of exome data from a family with and scientific evidence of the variant calls, reveals two siblings affected by Mabry syndrome (also known PIGO as the disease candidate gene and the muta- as hyperphosphatasia with mental retardation syn- tions were confirmed as the causative mutations of drome) demonstrates how effective the inheritance the disorder. filter reduced the amount of sequence variants. Starting with 27,584 variants the data was filtered CONCLUSION: The rule set, on which the filter is for genotype frequency (0.1%), and effects on pro- based, is comprehensive for analyzing multiple sam- tein level leaving over only 1446 variants. The com- ples and advances the prioritization of compound pound heterozygous filter reduces this set to just six heterozygous variants. It shows that filtering for variants in three distinct genes, NBPF10, MUC4, and compound heterozygous mutations is an effective PIGO. A quick assessment of the medical relevance means in identifying disease candidate genes especially when several family members are available for the analysis. In a trio analysis e.g. with exome data of the parents and one affected child, only about a dozen of variants in candidate genes remain after applying the filter. This manageable number of remaining genes can then be assessed based on the expertise of the investigator or further prioritized by suitable tools at www.Gene-Talk.de. REFERENCE: Krawitz PM, Murakami Y, Hecht J, Kruger U, Holder SE et al., Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet, 2012, 91: 146-151. Kamphans T, Sabri P, Zhu N, Heinrich V, Mundlos S, et al., Filtering for Compound Heterozygous Sequence Variants in NonConsanguineous Pedigrees. PLoS ONE, 2013, 8(8): e70151. www.gene-talk.de